(Reuters) -UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's therapy to treat a rare lung condition, marking another win for the drugmaker's ...

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

After a slow 2024, dealmaking in the U.S. healthcare sector is picking up. Springworks has a market value of $3 billion.

This update provides insights into critical global health developments, including Merck's halt on Gardasil shipments to China ...

Mere months after announcing a partnership to develop digital support tools for cancer patients, Huma Therapeutics and Merck KGaA have launched their first app in the UK. The new app is directed ...

as investors cheered robust earnings from the likes of UK's Experian and Germany's Commerzbank, while rate-sensitive stocks got a boost after a softer-than-expected U.S. inflation print. Merck ...

For the recently completed fourth quarter, Merck booked an adjusted profit of $1.72 per share on $15.6 billion in revenue. Sales of top-selling cancer treatment Keytruda climbed 19% to $7.84 billion.

As fraud reaches unprecedented levels, Merck Employees Federal Credit Union is taking action to enhance member experience and security by offering Carefull’s unique suite of proactive account ...